208 related articles for article (PubMed ID: 24357345)
21. Low-molecular weight chitosan/vascular endothelial growth factor short hairpin RNA for the treatment of hepatocellular carcinoma.
Huang Z; Dong L; Chen J; Gao F; Zhang Z; Chen J; Zhang J
Life Sci; 2012 Dec; 91(23-24):1207-15. PubMed ID: 23044224
[TBL] [Abstract][Full Text] [Related]
22. Optimization of multifunctional chitosan-siRNA nanoparticles for oral delivery applications, targeting TNF-α silencing in rats.
He C; Yin L; Song Y; Tang C; Yin C
Acta Biomater; 2015 Apr; 17():98-106. PubMed ID: 25662912
[TBL] [Abstract][Full Text] [Related]
23. Silencing of IL-6 and STAT3 by siRNA loaded hyaluronate-N,N,N-trimethyl chitosan nanoparticles potently reduces cancer cell progression.
Masjedi A; Ahmadi A; Atyabi F; Farhadi S; Irandoust M; Khazaei-Poul Y; Ghasemi Chaleshtari M; Edalati Fathabad M; Baghaei M; Haghnavaz N; Baradaran B; Hojjat-Farsangi M; Ghalamfarsa G; Sabz G; Hasanzadeh S; Jadidi-Niaragh F
Int J Biol Macromol; 2020 Apr; 149():487-500. PubMed ID: 32004600
[TBL] [Abstract][Full Text] [Related]
24. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
Li TS; Yawata T; Honke K
Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005
[TBL] [Abstract][Full Text] [Related]
25. Natural Particulates Inspired Specific-Targeted Codelivery of siRNA and Paclitaxel for Collaborative Antitumor Therapy.
Wang R; Zhao Z; Han Y; Hu S; Opoku-Damoah Y; Zhou J; Yin L; Ding Y
Mol Pharm; 2017 Sep; 14(9):2999-3012. PubMed ID: 28753317
[TBL] [Abstract][Full Text] [Related]
26. CD73 specific siRNA loaded chitosan lactate nanoparticles potentiate the antitumor effect of a dendritic cell vaccine in 4T1 breast cancer bearing mice.
Jadidi-Niaragh F; Atyabi F; Rastegari A; Kheshtchin N; Arab S; Hassannia H; Ajami M; Mirsanei Z; Habibi S; Masoumi F; Noorbakhsh F; Shokri F; Hadjati J
J Control Release; 2017 Jan; 246():46-59. PubMed ID: 27993599
[TBL] [Abstract][Full Text] [Related]
27. Cholesteryl oligoarginine delivering vascular endothelial growth factor siRNA effectively inhibits tumor growth in colon adenocarcinoma.
Kim WJ; Christensen LV; Jo S; Yockman JW; Jeong JH; Kim YH; Kim SW
Mol Ther; 2006 Sep; 14(3):343-50. PubMed ID: 16765648
[TBL] [Abstract][Full Text] [Related]
28. Codelivery of BV6 and anti-IL6 siRNA by hyaluronate-conjugated PEG-chitosan-lactate nanoparticles inhibits tumor progression.
Salimifard S; Karoon Kiani F; Sadat Eshaghi F; Izadi S; Shahdadnejad K; Masjedi A; Heydari M; Ahmadi A; Hojjat-Farsangi M; Hassannia H; Mohammadi H; Boroumand-Noughabi S; Keramati MR; Jadidi-Niaragh F
Life Sci; 2020 Nov; 260():118423. PubMed ID: 32941896
[TBL] [Abstract][Full Text] [Related]
29. [Inhibition of bladder cancer cell growth and angiogenesis by co-blockage of vascular endothelial growth factor and its receptor KDR].
Chen XL; Liu LC; Xu ZG; Li Z; Li RW; Gao RJ; Wang S; Zhang M; Guo H
Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):578-82. PubMed ID: 19102933
[TBL] [Abstract][Full Text] [Related]
30. Improvement of therapeutic efficacy of PLGA nanoformulation of siRNA targeting anti-apoptotic Bcl-2 through chitosan coating.
Jagani HV; Josyula VR; Palanimuthu VR; Hariharapura RC; Gang SS
Eur J Pharm Sci; 2013 Mar; 48(4-5):611-8. PubMed ID: 23291045
[TBL] [Abstract][Full Text] [Related]
31. Therapeutic potential of targeted multifunctional nanocomplex co-delivery of siRNA and low-dose doxorubicin in breast cancer.
Dong D; Gao W; Liu Y; Qi XR
Cancer Lett; 2015 Apr; 359(2):178-86. PubMed ID: 25592040
[TBL] [Abstract][Full Text] [Related]
32. Anti-Mucin1 Aptamer-Conjugated Chitosan Nanoparticles for Targeted Co-Delivery of Docetaxel and IGF-1R siRNA to SKBR3 Metastatic Breast Cancer Cells.
Jafari R; Majidi Zolbanin N; Majidi J; Atyabi F; Yousefi M; Jadidi-Niaragh F; Aghebati-Maleki L; Shanehbandi D; Soltani Zangbar MS; Rafatpanah H
Iran Biomed J; 2019 Jan; 23(1):21-33. PubMed ID: 30041514
[TBL] [Abstract][Full Text] [Related]
33. Therapy with siRNA for Vegf-c but not for Vegf-d suppresses wide-spectrum organ metastasis in an immunocompetent xenograft model of metastatic mammary cancer.
Shibata MA; Shibata E; Morimoto J; Harada-Shiba M
Anticancer Res; 2013 Oct; 33(10):4237-47. PubMed ID: 24122987
[TBL] [Abstract][Full Text] [Related]
34. Downregulation of CD73 in 4T1 breast cancer cells through siRNA-loaded chitosan-lactate nanoparticles.
Jadidi-Niaragh F; Atyabi F; Rastegari A; Mollarazi E; Kiani M; Razavi A; Yousefi M; Kheshtchin N; Hassannia H; Hadjati J; Shokri F
Tumour Biol; 2016 Jun; 37(6):8403-12. PubMed ID: 26733167
[TBL] [Abstract][Full Text] [Related]
35. Chitosan/VEGF-sIRNA nanoparticle for gene silencing.
Yang Y; Liu X; Zhang D; Yu W; Lv G; Xie H; Zheng J; Ma X
J Control Release; 2011 Nov; 152 Suppl 1():e160-1. PubMed ID: 22195822
[No Abstract] [Full Text] [Related]
36. Anti-angiogenic effects of CD73-specific siRNA-loaded nanoparticles in breast cancer-bearing mice.
Ghalamfarsa G; Rastegari A; Atyabi F; Hassannia H; Hojjat-Farsangi M; Ghanbari A; Anvari E; Mohammadi J; Azizi G; Masjedi A; Yousefi M; Yousefi B; Hadjati J; Jadidi-Niaragh F
J Cell Physiol; 2018 Oct; 233(10):7165-7177. PubMed ID: 29741783
[TBL] [Abstract][Full Text] [Related]
37. Chitosan/hyaluronic acid/plasmid-DNA nanoparticles encoding interleukin-1 receptor antagonist attenuate inflammation in synoviocytes induced by interleukin-1 beta.
Deng RH; Qiu B; Zhou PH
J Mater Sci Mater Med; 2018 Oct; 29(10):155. PubMed ID: 30276528
[TBL] [Abstract][Full Text] [Related]
38. [Inhibitation of tumor angiogenesis, growth and metastasis by blocking VEGF paracrine pathway].
Wang F; Tian YH; Li L; Chen XF; Hu HH; Li CY; Huang Q
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2002 Mar; 34(2):165-70. PubMed ID: 12006990
[TBL] [Abstract][Full Text] [Related]
39. VEGF-targeted RNA interference suppresses angiogenesis and tumor growth of retinoblastoma.
Jia RB; Zhang P; Zhou YX; Song X; Liu HY; Wang LZ; Luo M; Lu J; Ge SF; Fan XQ
Ophthalmic Res; 2007; 39(2):108-15. PubMed ID: 17284938
[TBL] [Abstract][Full Text] [Related]
40. A small interfering RNA targeting vascular endothelial growth factor inhibits Ewing's sarcoma growth in a xenograft mouse model.
Guan H; Zhou Z; Wang H; Jia SF; Liu W; Kleinerman ES
Clin Cancer Res; 2005 Apr; 11(7):2662-9. PubMed ID: 15814647
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
